Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose Halperin

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Pharmaceutical Design|February 3, 2004
Complement and complement regulatory proteins as potential molecular targets for vascular diseasesJuan Acosta, Xuebin Qin, Jose Halperin
Endocrine Reviews|April 21, 2026
Glycated CD59, a Novel Biomarker for Gestational DiabetesMichelle Toth Castillo, Shauntina Drayton Powell, Amy Biermann, et al.
BMJ Open|April 21, 2022
Plasma-glycated CD59 as an early biomarker for gestational diabetes mellitus: prospective cohort study protocolChloe Andrews, Michelle Toth-Castillo, Huseyin Aktas, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 20, 2023
The utility of plasma glycated CD59 in predicting postpartum glucose intolerance: A prospective study of women diagnosed with GDM during a period of universal GDM screeningDelia Bogdanet, Michelle T Castillo, Helen Doheny, et al.
Diabetes Research and Clinical Practice|July 30, 2022
The utility of first trimester plasma glycated CD59 (pGCD59) in predicting gestational diabetes mellitus: A prospective study of non-diabetic pregnant women in IrelandDelia Bogdanet, Michelle Toth Castillo, Helen Doheny, et al.
European Journal of Medicinal Chemistry|December 28, 2019
New activators of eIF2α Kinase Heme-Regulated Inhibitor (HRI) with improved biophysical propertiesQingwen Zhang, Ronghui Du, Guilherme Rodrigo Reis Monteiro Dos Santos, et al.
Diabetes Care|May 24, 2024
Risk of Neonatal Hypoglycemia in Infants of Mothers With Gestational Glucose IntoleranceChloe Andrews, Jacqueline Maya, Carolin C M Schulte, et al.
Journal of Molecular Biology|October 3, 2006
Mapping of the auto-inhibitory interactions of protein kinase R by nuclear magnetic resonanceVladimir Gelev, Huseyin Aktas, Assen Marintchev, et al.
Journal of Medicinal Chemistry|November 23, 2013
Explorations of substituted urea functionality for the discovery of new activators of the heme-regulated inhibitor kinaseTing Chen, Khuloud Takrouri, Sung Hee-Hwang, et al.
Journal of Medicinal Chemistry|June 8, 2017
Development of 1-((1,4-trans)-4-Aryloxycyclohexyl)-3-arylurea Activators of Heme-Regulated Inhibitor as Selective Activators of the Eukaryotic Initiation Factor 2 Alpha (eIF2α) Phosphorylation Arm of the Integrated Endoplasmic Reticulum Stress ResponseRevital Yefidoff-Freedman, Jing Fan, Lu Yan, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Pharmaceutical Design|February 3, 2004
Complement and complement regulatory proteins as potential molecular targets for vascular diseasesJuan Acosta, Xuebin Qin, Jose Halperin
Endocrine Reviews|April 21, 2026
Glycated CD59, a Novel Biomarker for Gestational DiabetesMichelle Toth Castillo, Shauntina Drayton Powell, Amy Biermann, et al.
BMJ Open|April 21, 2022
Plasma-glycated CD59 as an early biomarker for gestational diabetes mellitus: prospective cohort study protocolChloe Andrews, Michelle Toth-Castillo, Huseyin Aktas, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 20, 2023
The utility of plasma glycated CD59 in predicting postpartum glucose intolerance: A prospective study of women diagnosed with GDM during a period of universal GDM screeningDelia Bogdanet, Michelle T Castillo, Helen Doheny, et al.
Diabetes Research and Clinical Practice|July 30, 2022
The utility of first trimester plasma glycated CD59 (pGCD59) in predicting gestational diabetes mellitus: A prospective study of non-diabetic pregnant women in IrelandDelia Bogdanet, Michelle Toth Castillo, Helen Doheny, et al.
European Journal of Medicinal Chemistry|December 28, 2019
New activators of eIF2α Kinase Heme-Regulated Inhibitor (HRI) with improved biophysical propertiesQingwen Zhang, Ronghui Du, Guilherme Rodrigo Reis Monteiro Dos Santos, et al.
Diabetes Care|May 24, 2024
Risk of Neonatal Hypoglycemia in Infants of Mothers With Gestational Glucose IntoleranceChloe Andrews, Jacqueline Maya, Carolin C M Schulte, et al.
Journal of Molecular Biology|October 3, 2006
Mapping of the auto-inhibitory interactions of protein kinase R by nuclear magnetic resonanceVladimir Gelev, Huseyin Aktas, Assen Marintchev, et al.
Journal of Medicinal Chemistry|November 23, 2013
Explorations of substituted urea functionality for the discovery of new activators of the heme-regulated inhibitor kinaseTing Chen, Khuloud Takrouri, Sung Hee-Hwang, et al.
Journal of Medicinal Chemistry|June 8, 2017
Development of 1-((1,4-trans)-4-Aryloxycyclohexyl)-3-arylurea Activators of Heme-Regulated Inhibitor as Selective Activators of the Eukaryotic Initiation Factor 2 Alpha (eIF2α) Phosphorylation Arm of the Integrated Endoplasmic Reticulum Stress ResponseRevital Yefidoff-Freedman, Jing Fan, Lu Yan, et al.
Pageof 1